中财网 中财网股票行情
迪哲医药(688192)财务分析指标    年份：
截止日期2026-09-302026-06-302026-03-312025-12-312025-09-30
营业总收入(万元)476956.4252269.2725252.1980113.5658630.11
营业收入(万元)476956.4252269.2725252.1980113.5658630.11
营业总成本(万元)116648.4175930.4636528.73165417.85123549.01
营业成本(万元)3712.992089.111029.053422.892532.52
净利润(万元)363877.53-21037.34-9555.74-76404.95-57994.78
归属于母公司的净利润(万元)363877.53-21037.34-9555.74-76404.95-57994.78
营业利润(万元)363451.99-21262.47-9636.64-76636.27-58290.11
利润总额(万元)363468.35-21246.22-9634.23-76712.67-58290.11
少数股东损益(万元)-448.61-272.22-114.48-446.80-300.54
基本每股收益(元)7.83(元)-0.45(元)-0.21(元)-1.71(元)-1.32(元)
稀释每股收益(元)7.83(元)-0.45(元)-0.21(元)-1.71(元)-1.32(元)
非经常性损益(万元)----1327.52--5071.31
扣除非经常性损益后净利润(万元)361205.36-23123.66-10883.26-84155.30-63066.09
总资产(万元)665065.56284786.30301301.97300252.92295534.66
总负债(万元)166915.71171874.27177783.89170683.83151161.32
归属于母公司股东权益合计(万元)498415.14113000.93123449.25129385.77144043.77
股东权益合计(万元)498149.85112912.03123518.08129569.08144373.34
实收资本(股本)(万元)46516.5846516.5846463.3346118.7945941.29
资本公积(万元)500378.09499878.75498898.72495624.05492049.38
未分配利润(万元)-48479.53-433394.40-421912.80-412357.06-393946.89
经营活动产生的现金流量净额(万元)364935.43-27430.78-20047.76-58832.48-42405.68
经营活动现金流入小计(万元)490740.3153917.7426906.6284612.7459511.67
经营活动现金流出小计(万元)125804.8881348.5146954.38143445.22101917.36
投资活动产生的现金流量净额(万元)23985.535523.91-9343.45-119870.88-45203.33
投资活动现金流入小计(万元)534652.02364353.62189647.90996876.02728291.00
投资活动现金流出小计(万元)510666.49358829.71198991.351116746.90773494.33
筹资活动产生的现金流量净额(万元)3685.2510705.1322634.62182868.49164090.84
筹资活动现金流入小计(万元)47250.8147250.8142530.81260414.35233358.57
筹资活动现金流出小计(万元)43565.5536545.6819896.1977545.8669267.73
期末现金及现金等价物余额(万元)421327.6517886.4122342.2129114.66101448.46
最后修改日期2026-10-302026-08-202026-04-302026-03-302025-11-01
↑返回页顶↑

转至迪哲医药（688192）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。